Biotechnology | Healthcare
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
Market Cap
4268524032
Current Price
119.84
52 Week Range
96.8 - 176.59
Previous Close
116.74
Open
117.5
Industry
Biotechnology
Sector
Healthcare
Address
Spencer Building, Ground Floor 30, Forjett Street Grant Road (West), Mumbai, 400036, India
Phone
+91-22661-12200
Fax
+91-22661-12248
Website
https://www.lykalabs.com
Day Low
116.99
Day High
120.42
Dividend Yield
PE Ratio
53.392857
Earnings Per Share
2.24
Beta
0.549
EBITDA
179350000
Book Value
28.642
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Kunal Narendra Gandhi | MD, CEO & Director | 37 | 1987 |
Mr. Yogesh Babulal Shah | CFO & Executive Director | 64 | 1960 |
Mr. Shekhar R. Singh | Company Secretary & Compliance Officer | - | - |
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Healthcare • Biotechnology
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.